Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for treatment of spasticity in multiple sclerosis
2005-001776-13Phase 3Active
- Sponsor
- Organisation name was not entered
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levetiracetam in multiple sclerosis (MS) (2 arms), sponsored by Organisation name was not entered. Primary endpoint: Improvement of spasticity scores. Started Sep 2006; status: active.
02
Drugs
levetiracetam
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-001776-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001776-13.